Tenet Healthcare Corp (THC)
UndervaluedFundamental
69
मूल्य
$255.56
मार्केट कैप
$20.77B
भाग 1 · कंपनी का मूल्य कितना है
अवलोकन
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
बैलेंस शीट और तरलता
राजस्व
$21.81B
पिछले 12 महीने (30/6/2026 तक)
शुद्ध आय
$3.17B
पिछले 12 महीने (30/6/2026 तक)
Free Cash Flow
$2.53B
कुल इक्विटी
$4.22B
कुल देनदारियाँ
$20.70B
Current Ratio
1.41
Interest Coverage
5.54
Debt/EBITDA
3.03
Earnings Per Share
राजस्व और शुद्ध आय
Free Cash Flow
आय विवरण
ऐतिहासिक विवरण
समय के साथ मार्जिन
समय के साथ ऋण
ऋण कितना भारी है
वृद्धि तालिका
वृद्धि — राजस्व
Fair Value अनुमान
Fair Value
$610.78
वर्तमान मूल्य
$255.56
Margin of Safety
+58.2%
Fair Value सीमा
$397.01 - $824.55
इस्तेमाल किए गए valuation methods के बीच का फैलाव, कोई सांख्यिकीय रूप से calibrated confidence interval नहीं।
अनुमान विधियाँ
मूल्यांकन मेट्रिक्स
P/E Ratio
9.86
ROE
56.1%
P/B Ratio
4.42
P/FCF
6.81
Gross Margin
-
ROIC
14.3%
लाभप्रदता Radar
मूल्य सृजन (प्रतिस्पर्धी बढ़त)
ROIC
14.3%
WACC
8.8%
ROIC − WACC
+5.5 pp
ROIC पूंजी की लागत से अधिक है — कंपनी शेयरधारकों के लिए मूल्य सृजित कर रही है।
Fundamental विश्लेषण मानदंड
पास (18)
- EPS shows upward trend
- EPS CAGR 40.13%
- Price CAGR 33.35%
- ROIC 14.3%
- P/FCF 6.81
- Operating Margin 20.8%
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 50.6%
- Analyst Consensus 85% Buy
- Earnings Surprise avg 20.9%
- PEG Ratio 0.28
- Earnings Quality (OCF/NI) 1.26
- Net Margin Trend 14.6% vs 11.6%
- Piotroski F-Score 5/9
फेल (8)
- P/B Ratio 4.42
- Debt/Equity ratio
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Revenue Growth 5Y 3.9%
- Share Dilution 23.0%
अनुपलब्ध (2)
- Gross Margin NaN%
- Dividend Payout NaN%
Piotroski F-Score
मिश्रित संकेत: कुछ क्षेत्रों पर ध्यान देना आवश्यक
Earnings गुणवत्ता
उच्च गुणवत्ता: earnings नकदी द्वारा समर्थित
शेयर Dilution
नए शेयर जारी कर रही है, स्वामित्व को कम कर रही है
संस्थागत होल्डिंग
प्रशासन
कार्यकारी टीम
| नाम | पद | आयु |
|---|---|---|
| Dr. Saumya Sutaria M.D. | Chairman & CEO | 52 |
| Mr. Sun K. Park | Executive VP & CFO | 49 |
| Ms. Lisa Y. Foo | Executive VP & Chief Operating Officer | 34 |
| Ms. Paola M. Arbour | Executive VP & Chief Information Officer | 61 |
| Mr. Thomas W. Arnst | EVP, Chief Administrative Officer, Chief Risk Officer, General Counsel & Corporate Secretary | 62 |
| Mr. John Michael Grooms | Senior VP, Controller & Principal Accounting Officer | 47 |
| Mr. William McDowell III | Vice President of Investor Relations | - |
| Ms. Jana Durfee | Senior VP & Chief Compliance Officer | - |
| Mr. Michael T. Maloney | Executive Vice President of Corporate Development | - |
| Mr. Clint Hailey | Chief Managed Care Officer & Senior VP | 60 |
Audit जोखिम
4
बोर्ड जोखिम
3
मुआवजा जोखिम
2
शेयरधारक अधिकार जोखिम
1
भाग 2 · कीमत और खरीदने का समय
यह हिस्सा यह नहीं बताता कि कंपनी अच्छी है या नहीं: यह तय करने में मदद करता है कि उसे कब खरीदें, जब फंडामेंटल आपको आश्वस्त कर चुके हों। इसमें: तकनीकी विश्लेषण, संभावना, ऐतिहासिक गिरावट, गामा एक्सपोज़र।
दस्तावेज़
- दस्तावेज़ देखें
वार्षिक रिपोर्ट (10-K)
कंपनी के कारोबार, वित्तीय नतीजों और जोखिमों का वार्षिक सिंहावलोकन।
दाखिल तिथि: 2026-02-17
- दस्तावेज़ देखें
तिमाही रिपोर्ट (10-Q)
पिछले तीन महीनों के वित्तीय प्रदर्शन का अपडेट।
दाखिल तिथि: 2026-07-29
- दस्तावेज़ देखें
विशेष रिपोर्ट (8-K)
किसी बड़ी घटना, जैसे नेतृत्व में बदलाव या बड़ी घोषणा, की सूचना।
दाखिल तिथि: 2026-09-22
via SEC EDGAR
आय का इतिहास
via SEC EDGAR
Latest News
Recent headlines for THC, sourced from Markets Gazette.
- 2/20/2026POSITIVEThe Analyst Verdict: Tenet Healthcare In The Eyes Of 12 Experts
Recent analyst ratings for Tenet Healthcare (THC) show a predominantly positive sentiment, with multiple experts maintaining or reinstating "Buy" ratings. This suggests a favorable outlook for the stock, based on fundamental analysis or future growth prospects.
via Markets Gazette